The Pershing Square Foundation today announced the 2026 Lotus Award (formerly the Ovarian Cancer Challenge Grant), a competitive funding program to accelerate breakthrough research in ovarian cancer.

“By spotlighting ovarian cancer, we’re expanding the frontier of cancer research to where it’s most urgently needed. This initiative brings together scientific excellence, bold thinking, and a ...

(New York, May 29, 2025) – Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the ...

A sponge-like gold nanoparticle platform could deliver faster, more accurate, and less invasive ovarian cancer diagnostics.

Participants in Ride the Teal Wave can kayak or paddleboard. Onlookers are also welcome. Courtesy of Kari Neumeyer Courtesy to The Bellingham Herald Ride the Teal Wave, a paddling fundraiser at ...

A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve ...

AWARENESS MONTH, AND LSU HEALTH WANTS TO MAKE SURE ALL OF THE LADIES IN LOUISIANA ARE HAPPY AND HEALTHY, AND THEY’VE GOT AN UPCOMING EVENT RAISING MONEY TO SUPPORT THE IMPORTANT CANCER CARE SOME WOMEN ...

Figure 1: Hemocytometer dead cells count. Here is the bar graph showing the hemocytometer based dead cell counts for each treatment group across day 1, day 2 and day 4 (24 hours post treatment). The ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...